Stock Events

Stock Events

Mesoblast 

€1.33
0
+€0.02+1.76% Tuesday 15:03

Statistics

Day High
1.33
Day Low
1.29
52W High
1.7
52W Low
0.85
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26FebExpected
Q4 2025
-0.03
-0.02
-0.02
-0.02
Expected EPS
-0.020081483999999997
Actual EPS
-0.026351652

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LWB.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biolife Solutions
BLFS
Mkt Cap1.04B
BioLife Solutions provides bioproduction tools and services, including cell and gene therapy solutions, which are essential for companies like Mesoblast, making them a competitor in the supply chain.
Fate Therapeutics
FATE
Mkt Cap177.91M
Fate Therapeutics is focused on developing programmed cellular immunotherapies for cancer and immune disorders, competing with Mesoblast in the cell therapy and regenerative medicine market.
CRISPR Therapeutics
CRSP
Mkt Cap4.98B
CRISPR Therapeutics is engaged in gene editing and gene-based medicine, competing with Mesoblast in the broader regenerative medicine and cell therapy sector.
Vericel
VCEL
Mkt Cap1.81B
Vericel Corporation focuses on autologous cell therapies for the treatment of patients with serious diseases and conditions, directly competing with Mesoblast's therapeutic areas.
NovoCure
NVCR
Mkt Cap1.92B
NovoCure operates in the oncology sector with a novel therapy, competing indirectly with Mesoblast by targeting some of the same diseases but with different therapeutic approaches.
Sangamo Therapeutics
SGMO
Mkt Cap55.93M
Sangamo Therapeutics focuses on genomic medicine, including gene therapy, competing with Mesoblast in the innovative treatment sector for genetic and complex diseases.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.45B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, competing with Mesoblast in the broader market for novel therapies.

About

There is no Profile data available for LWB.MU.
Show more...
CEO
Country
Germany
ISIN
AU000000MSB8

Listings

MU
DE
LWB.MU
STU
DE
LWB.STU
STU
DE
LWB1.STU
MU
DE
LWB1.MU

0 Comments

Share your thoughts

FAQ

What is Mesoblast stock price today?▼
The current price of LWB.STU is €1.33 EUR — it has increased by +1.76% in the past 24 hours. Watch Mesoblast stock price performance more closely on the chart.
What is Mesoblast stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mesoblast stocks are traded under the ticker LWB.STU.
Is Mesoblast stock price growing?▼
LWB.STU stock has risen by +1.37% compared to the previous week, the month change is a +7.1% rise, over the last year Mesoblast has showed a +37.62% increase.
When is the next Mesoblast earnings date?▼
Mesoblast is going to release the next earnings report on September 02, 2026.
What were Mesoblast earnings last quarter?▼
LWB.STU earnings for the last quarter are -0.03 EUR per share, whereas the estimation was -0.02 EUR resulting in a -31.22% surprise. The estimated earnings for the next quarter are N/A EUR per share.
In which sector is Mesoblast located?▼
Mesoblast operates in the Other sector.
When did Mesoblast complete a stock split?▼
Mesoblast has not had any recent stock splits.